FindTrial
Sign In

Genetic and clinical study of adrenal tumor causing high blood pressure

Genotype-Phenotype Correlation in Asian-Indian Patients with Pheochromocytoma / Paraganglioma (PHEO/PGL)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/02/003391
Enrollment
200
Registered
2013-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pheochromocytoma/Paraganglioma

Interventions

None listed

Sponsors

Diamond Jubilee Society Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histologically proven cases of PHEO/PGL

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
This study is expected to unravel the incidence of germline mutations in clinically screened pheochromocytoma/paraganglioma patients and their penetrance in the Indian population.Timepoint: 5 years—

Secondary

MeasureTime frame
The correlation between the clinical and genetic profiles seeks to optimize genetic counseling, thus furthering patient careTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Nalini S Shah

Seth G.S.Medical College and K.E.M. Hospital

reshmap9@gmail.com02224162917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026